Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/10/2019
SIETES contiene 92824 citas

 
 
 1 a 15 de 15 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ 2014;348:g1626. [Ref.ID 97343]
2.
Nolla-Salas J, Gracia MP, Martín JC, del Baño F. Golpe de calor en pacientes tratados con topiramato. Med Clin (Barc) 2007;128:677-8. [Ref.ID 80151]
3.
Haddow AM, Harris D, Wilson M, Logie H. Clomipramine induced neuroleptic malignant syndrome and pyrexia of unknown origin. BMJ 2004;329:1333-5. [Ref.ID 72086]
4. Cita con resumen
Anónimo. Risques liés aux médicaments en cas de vague de chaleur. Prescrire 2004;24:505-11. [Ref.ID 70759]
5. Cita con resumen
Anónimo. Metabolic acidosis risk with Topamax. Scrip 2004;2915:24. [Ref.ID 68653]
6. Cita con resumen
Anónimo. Topiramate: revised prescribing information. United States of America/Canada. WHO Drug Information 2003;17:169. [Ref.ID 67570]
8. Cita con resumen
Anónimo. Topiramate warnings updated by the US FDA. Scrip 2003;2867:20. [Ref.ID 66715]
9.
Crandall CG, Vongpatanasin W, Victor RG. Mechanism of cocaine-induced hyperthermia in humans. Ann Intern Med 2002;136:785-91. [Ref.ID 62398]
10.
Fanning MM, Wassel R, Piazza-Hepp T. Pyrogenic reactions to gentamicin therapy. N Engl J Med 2000;343:1658-9. [Ref.ID 53979]
11.
van der Zee J, González González D, van Rhoon GC, van Dijk JDP, van Putten WLJ, Hart AAM, for the Dutch Deep Hyperthermia Group. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Lancet 2000;355:1119-25. [Ref.ID 50179]
12.
Vanakoski J, Seppälä T. Heat exposure and drugs: a review of the effects of hyperthermia on pharmacokinetics. Clin Pharmacokinet 1998;34:311-22. [Ref.ID 39246]
13. Cita con resumen
Reith J, Jorgensen HS, Pedersen P M, Nakayama H, Raaschou H O, Jeppesen LL, Olsen TS. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996;347:422-5. [Ref.ID 25994]
14.
Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 1992;340:384-7. [Ref.ID 17947]
15.
Farber EM, Nall L. Psoriasis: a review of recent advances in treatment. Drugs 1984;28:324-46. [Ref.ID 8446]
Seleccionar todas
 
 1 a 15 de 15